FDA.reportPublic FDA data

nerandomilast 9 MG Oral Tablet

RxCUI
2725528
RxNorm name
nerandomilast 9 MG Oral Tablet
Display name
nerandomilast 9 MG Oral Tablet
Full name
nerandomilast 9 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JASCAYDNERANDOMILASTBoehringer Ingelheim Pharmaceuticals, Inc.fa1b14c6-957f-d326-5099-911bfe33e3912026-08-14Adverse reactionsExact identifier
rxcui: 2725528

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
fa1b14c6-957f-d326-5099-911bfe33e391nerandomilast 9 MG Oral Tablet [PSN] · nerandomilast 9 MG Oral Tablet [SCD]24These highlights do not include all the information needed to use JASCAYD safely and effectively. See full prescribing information for JASCAYD. JASCAYD ® (nerandomilast tablets), for oral use Initial U.S. Approval: 202520260202